RxMen, a Delhi-based men’s health tech startup, has raised ₹5 crore ($570K) in its seed funding round led by Inflection Point Ventures (IPV). The round also saw participation from SPA Family Ventures, Ankit Goel, Seven Square Ventures, along with a grant from Prosus Group.
The startup will use the funds for brand building, launching RxMen-branded products, and setting up co-branded clinics, with a target of achieving positive EBITDA by October 2025.
Founded in 2023 by Shailja Mittal, RxMen is a full-stack, clinic-led men’s health platform focused on root-cause treatment across sexual health, hormones, skin, stress, and sleep.
In just 20 months, RxMen has:
-
Grown 100x in revenue
-
Reported MRR of $70,000 (Aug 2025) with ARR projection of $1.7M in FY26
-
Delivered 30,000+ consultations to date
-
Scaled to 6,000 monthly consultations with a 30-specialist network spanning urology, psychiatry, sexology & therapy
The company has also built a proprietary Sexual Health Index (SHI) based on 25,000 anonymized consultations, currently under validation at IIT Jodhpur, with reported 95% success rates in outcomes.
“Men’s health remains deeply underserved in India, with stigma often preventing early care. At RxMen, we are building a tech-driven, clinic-first platform to normalize men’s health conversations while delivering evidence-based treatment,” said Shailja Mittal, Founder of RxMen.
The men’s health market in India is heating up, with RxMen competing against well-funded players like Man Matters (Mosaic Wellness), Bold Care, and Traya.
By: Arushi Agarwal
